GlassScriptPhysician profile
Benjamin T Wood
NPI 1093904468
$377.93
in general payments reported to CMS, 2019-2025
14 companies · $41.53 in 2025
The $41.53 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.36 · 2022: $102 · 2023: $115 · 2024: $78.47 · 2025: $41.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.92 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $46.47 | 2022 | |
| Abbvie INC. | $41.85 | 2019-2022 | |
| Astellas Pharma US INC | $40.17 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $31.50 | 2019-2023 | |
| Biogen, INC. | $23.41 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $23.13 | 2023 | |
| Medicem INC. | $20.27 | 2024 | |
| Daiichi Sankyo INC. | $18.95 | 2023 | Injectafer |
| Meditrina | $18.12 | 2025 | |
| Glaxosmithkline, LLC. | $16.18 | 2022 | |
| Minerva Surgical, INC | $14.41 | 2023 | |
| Therapeuticsmd, INC. | $13.52 | 2019 | |
| Exeltis, USA INC. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.